Literature DB >> 8553571

Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-I LTR.

E F Meurs1, N McMillan, B R Williams, A G Hovanessian, P J Southern.   

Abstract

We have analyzed the effect of transfection into murine NIH/3T3 cells of the human dsRNA-activated kinase PKR on the expression of the beta-galactosidase reporter gene, placed under control of the HIV1 or the HTLV-I LTR. beta-Galactosidase expression is stimulated when the reporter plasmids are cotransfected with wild-type PKR but inhibited when cotransfected with a catalytically inactive mutant PKR. In the case of HIV1, beta-galactosidase expression was not stimulated when cotransfection was carried out with PKR harboring mutations in the dsRNA binding domains, indicating that stimulation depends on the classical mode of PKR activation through dsRNA binding. In contrast, the dsRNA binding mutants of PKR could still partially stimulate beta-galactosidase expression from the HTLV-I LTR, suggesting that PKR activation in this case may involve different/additional mechanisms. These results show that, in addition to the known down-regulation of protein synthesis through elF2 phosphorylation, PKR can also positively stimulate gene expression in vivo, most probably through phosphorylation of a substrate distinct from elF2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553571     DOI: 10.1006/viro.1995.0080

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.

Authors:  C DeLuca; A Roulston; A Koromilas; M A Wainberg; J Hiscott
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.

Authors:  M C Bonnet; R Weil; E Dam; A G Hovanessian; E F Meurs
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

5.  Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR.

Authors:  K Nagai; A H Wong; S Li; W N Tam; A R Cuddihy; N Sonenberg; M B Mathews; J Hiscott; M A Wainberg; A E Koromilas
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.

Authors:  Kyung-Soo Chang; Zhaohui Cai; Chen Zhang; Ganes C Sen; Bryan R G Williams; Guangxiang Luo
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.

Authors:  C François; G Duverlie; D Rebouillat; H Khorsi; S Castelain; H E Blum; A Gatignol; C Wychowski; D Moradpour; E F Meurs
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.

Authors:  Adam K Wheatley; Marit Kramski; Marina R Alexander; Jesse G Toe; Rob J Center; Damian F J Purcell
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  HIV-1 Tat protein enhances the intracellular growth of Leishmania amazonensis via the ds-RNA induced protein PKR.

Authors:  Áislan de Carvalho Vivarini; Renata de Meirelles Santos Pereira; Victor Barreto-de-Souza; Jairo Ramos Temerozo; Deivid C Soares; Elvira M Saraiva; Alessandra Mattos Saliba; Dumith Chequer Bou-Habib; Ulisses Gazos Lopes
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.